Pluri Inc. Other Receivables
Pluri Inc. (PLUR) had Other Receivables of $10.00 thousand as of 2024-06-30, per its 10-K filed 2024-09-18.
Discontinued › Notes › Nontrade Receivables › Nontrade Receivables, Unclassified
us-gaap:OtherReceivables · last filed 2024-09-18
- 2024-06-30: Other Receivables $10.00K.
- 2023-06-30: Other Receivables $38.00K.
- 2022-06-30: Other Receivables $22.00K.
- 2020-06-30: Other Receivables $26.00K.
| Period end | Other Receivables |
|---|---|
| 2024-06-30 | $10.00K 10-K · filed 2024-09-18 |
| 2023-06-30 | $38.00K 10-K · filed 2024-09-18 |
| 2022-06-30 | $22.00K 10-K · filed 2023-09-12 |
| 2020-06-30 | $26.00K 10-K · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |